10 projets européens trouvés
Recherche sur 125080 projets européens
TERMINÉ
Big Data and models for personalized Head and Neck Cancer Decision support (BD2Decide)
Date du début: 1 janv. 2016, Date de fin: 30 avr. 2019,
"Cancers of the Head and Neck Region (HNC) are the 6th more deadly cancers worldwide: in Europe ~150.000 new cases are detected and ~70.000 patients die every year. The main reasons for high mortality are the fact that the majority of cases are diagnosed in advanced Stage and the intrinsic heterogeneity of such tumors. At present the only adopted treatment decision method is based on TNM (Tumor-ly ...
Voir le projet
13
Participants partenaires
TERMINÉ
Validating predictive models of radiotherapy toxicity to improve quality-of-life and reduce side-effects in cancer survivors (REQUITE)
Date du début: 1 oct. 2013, Date de fin: 30 sept. 2018,
Long-term side-effects of radiotherapy impact on the quality-of-life (QoL) of cancer survivors. These side-effects could be reduced if predicted in advance. Previous work identified clinical and biological predictors but a major, coordinated approach is needed to validate them so they can be used clinically. The EU has ~17.8 million people living with a prior diagnosis of cancer of whom ~7 million ...
Voir le projet
15
Participants partenaires
TERMINÉ
QUantitative Imaging in Cancer: CONnecting CEllular Processes with Therapy (QUIC-CONCEPT)
Date du début: 1 sept. 2011, Date de fin: 31 déc. 2017,
The QuIC-ConCePT consortium has 2 objectives: 1.(90% of resource, WP2-5) to qualify 3 specific imaging biomarkers (IBs) of tumour cell proliferation, apoptosis, and necrosis, to allow drug developers to demonstrate reliably modulation of these pathologic processes in tumours in patients in realistic trials. Our vision for January 2016 is that drug developers can incorporate these IBs for decision- ...
Voir le projet
26
Participants partenaires
TERMINÉ
Adaptive and innovative Radiation Treatment FOR improving Cancer patients treatment outcomE (ARTFORCE)
Date du début: 1 avr. 2011, Date de fin: 30 sept. 2017,
Loco-regional treatment is the mainstay of cancer cures in non small lung and head and neck cancer. For advanced stage cancer, dose intense multimodality treatment is required yet affected by substantial side effects. Our aim is to improve treatment outcome in locally advanced head and neck and lung cancer patients by:1. Optimizing local control by introducing novel radiation techniques resulting ...
Voir le projet
14
Participants partenaires
TERMINÉ
Enabling information re-Use by linking clinical REsearch and CAre (EURECA)
Date du début: 1 févr. 2012, Date de fin: 31 juil. 2015,
Description
EURECA (Enabling information re-Use by linking clinical REsearch and Care) aims to enable seamless, secure, scalable and consistent linkage of healthcare information, which resides in electronic health record (EHR) systems with information in clinical research information systems, such as clinical trials. Achieving semantic inter ...
Voir le projet
20
Participants partenaires
TERMINÉ
Metastatic tumours facilitated by hypoxic tumour micro-environments (METOXIA)
Date du début: 1 févr. 2009, Date de fin: 31 juil. 2014,
"Recent research suggests that the hypoxic micro-environment of tumours is one of the major drivers of metastatic spread of cancer. Furthermore, hypoxic tumour micro-environments may result in treatment resistance of cancer cells, therefore causing a double effect of reducing the potential of a successful treatment of the cancer patient. This project seeks to clarify the roles and functions of the ...
Voir le projet
21
Participants partenaires
TERMINÉ
European NoVel Imaging Systems for ION therapy (ENVISION)
Date du début: 1 févr. 2010, Date de fin: 31 juil. 2014,
Following the pioneering experiences which lasted several decades, particle therapy has become a recognized way of curing cancer. 2 new European dual-ion facilities (Heidelberg, Pavia) will soon become operational, followed by several others which are today at different stages of planning and construction. Hadron therapy faces the challenge of improving treatment outcomes with tools able to provid ...
Voir le projet
16
Participants partenaires
TERMINÉ
Low Energy Gamma and X-ray therapy (LOGX)
Date du début: 1 oct. 2009, Date de fin: 3 janv. 2014,
"Cancer is a serious disease with high mortality and morbidity. Treatment is often performed with radiation therapy. To assure a good control of the tumour with limited side effect, a very high conformity of the radiation field is needed in the treatments. This led to the development of very complex treatments using external photon beam. There is however another, more cost-effective, way to achiev ...
Voir le projet
1
Participant partenaire
TERMINÉ
uroCat (EuroCat)
Date du début: 31 mai 2009, Date de fin: 29 oct. 2013,
L’objectif poursuivi par le projet EUROCAT est double : a) le développement d’une base de données commune intégrant les caractéristiques des patients cancéreux, des tumeurs et des traitements. La copie des données provenant des bases de données existantes et leur mise en commun à une grande échelle permettra de faire progresser les connaissances sur le cancer et donnera la possibilité aux scientif ...
Voir le projet
7
Participants partenaires
TERMINÉ
Development of a Spatio-Temporal-Energetic Radiation Research Platform for Animals (STERRPA)
Date du début: 1 janv. 2009, Date de fin: 31 déc. 2012,
"In modern radiotherapy complex radiation fields are applied on cancer patients to eradicate cancer cells, while sparing the surrounding healthy tissue. In stark contrast, irradiation systems for small animals bear almost no resemblance to this paradigm. Usually these systems only administer large radiation fields which can not be modulated in their spatio-temporal aspect. Consequently, many anima ...
Voir le projet